Researchers from The University of Texas MD Anderson Cancer Center have discovered a previously unknown mechanism that explains how bacteria can drive treatment resistance in patients with oral and colorectal cancer.

Researchers Eduard Porta and Daniela Grases have just published the first practical guide on the use of Spatial Transcriptomics. Thanks to their experience, resulting from processing of more than 1,000 tissue samples in the laboratory, the Spatial Biology program at the Josep Carreras Leukemia Research Institute is now a leading expert in the use of this technology, essential for better understanding blood cancers and advancing in the development of new therapies. This is a fundamental aspect of the Josep Carreras Institute's new mission, which seeks to transform the way patients with hematologic cancer are diagnosed and treated.

Healing doesn’t end with treatment. As cancer survivorship grows, many continue to struggle with anxiety and depression – often in silence. A new review highlights how caring-healing modalities (CHMs) like mindfulness and peer support can build resilience and reduce emotional distress. These human-centered approaches shift focus from treatment to healing, helping survivors reclaim their sense of self. Rooted in empathy and emotional expression, CHMs offer a whole-person approach that meets the deep psychological needs often overlooked in survivorship care –especially among breast cancer survivors.

Controlling the state of a cell in a desired direction is one of the central challenges in life sciences, including drug development, cancer treatment, and regenerative medicine. However, identifying the right drug or genetic target for that purpose is extremely difficult. To address this, researchers at KAIST have mathematically modeled the interaction between cells and drugs in a modular “Lego block” manner—breaking them down and recombining them—to develop a new AI technology that can predict not only new cell–drug reactions never before tested but also the effects of arbitrary genetic perturbations.

POSTECH-UCLA Collaborative Team Develops Novel ‘Univody’ Platform for Antigen-Independent Cancer Immunotherapy.

July 10, 2025 - A research team led by Professor Yiwei Li and Professor Bi-Feng Liu from the College of Life Science and Technology at Huazhong University of Science and Technology (HUST) published an important research article titled "Mechanical Cell Reprogramming on Tissue-Mimicking Hydrogel for Cancer Cell Transdifferentiation" in the journal Research. The paper can be accessed through this link: https://spj.science.org/doi/10.34133/research.0810.

Professor Yiwei Li and Professor Bi-Feng Liu serve as corresponding authors, with doctoral students Xueqing Ren and Research Scientist Dr. Yachao Wang as co-first authors.

This study developed an innovative tissue-mimicking hydrogel system that achieves cell reprogramming through purely mechanical signals for the first time. The technology not only enhances the stemness and bidirectional differentiation potential of fibroblasts but also promotes cancer cell transdifferentiation into adipocytes, providing novel therapeutic strategies for regenerative medicine and cancer treatment.